Prestige Consumer Healthcare Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Prestige Consumer Healthcare Inc.
Beauty and consumer health care weren’t among the the consumer packaged goods categories showing private label market-share growth during April-June period. Consumer health industry executives see more spending on private label in some categories but without affecting their results.
Perrigo will note regulatory approval for Opill as first US OTC oral contraceptive in first earnings briefing with Patrick Lockwood-Taylor at helm. Other firsts in sector will be Kenvue’s 20 July results being its first since spin-out from J&J in May and Bausch + Lomb’s first quarterly results under CEO Saunders.
“Get To Good” campaign features “characters who embody the Goody’s consumer, leading active lives and refusing to be slowed down by pain,” while Dramamine’s “Ditch the Drama Sweepstakes” offers “dream vacation anywhere in the world” and introduces “Drama Llama” as “spokescharacter.”
Hydration Pharmaceuticals Company’s Hydralyte revenues come from limited footprint in rapidly growing sports beverage market while Prestige Consumer Healthcare’s Hydralyte footprint is limited only by not competing with Hydration Pharmaceuticals in US and Canada.
- OTC, Consumer
- Other Names / Subsidiaries
- Prestige Brands, Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.